Covidien (COV) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Other (expense) income, net: -20M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other (expense) income, net: -20M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q2 EPS of $1.12, $0.03 better than the analyst estimate of $1.09. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.12 billion.
For earnings history and earnings-related data on Covidien (COV) click here.
For earnings history and earnings-related data on Covidien (COV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
